Cargando…
LncRNA PDCD4-AS1 alleviates triple negative breast cancer by increasing expression of IQGAP2 via miR-10b-5p
OBJECTIVE: Mounting evidence demonstrates that long non-coding RNA (lncRNA) is dysregulated in breast cancers. This study was designed to detect the influences and regulatory mechanism of lncRNA PDCD4-AS1 in triple-negative breast cancer (TNBC). METHODS: qRT-PCR and Western blot were utilized to inv...
Autores principales: | Wang, Daoliang, Wang, Zhuo, Zhang, Lijun, Sun, Shengrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704410/ https://www.ncbi.nlm.nih.gov/pubmed/33248413 http://dx.doi.org/10.1016/j.tranon.2020.100958 |
Ejemplares similares
-
LncRNA SNHG10 suppresses the development of doxorubicin resistance by downregulating miR-302b in triple-negative breast cancer
por: Aini, Shataer, et al.
Publicado: (2022) -
LncRNA PAPAS may promote triple-negative breast cancer by downregulating miR-34a
por: Kong, Yan, et al.
Publicado: (2019) -
Bone-targeted lncRNA OGRU alleviates unloading-induced bone loss via miR-320-3p/Hoxa10 axis
por: Wang, Ke, et al.
Publicado: (2020) -
LncRNA LUCAT1 facilitates tumorigenesis and metastasis of triple-negative breast cancer through modulating miR-5702
por: Mou, Exian, et al.
Publicado: (2019) -
lncRNA MIR4435-2HG Accelerates the Development of Bladder Cancer through Enhancing IQGAP3 and CDCA5 Expression
por: Yang, Tao, et al.
Publicado: (2022)